Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-024416
Filing Date
2021-02-16
Accepted
2021-02-16 17:28:21
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm216714-2_5seq1.html 5  
1 OWNERSHIP DOCUMENT tm216714-2_5seq1.xml 5 9085
  Complete submission text file 0001104659-21-024416.txt   10411
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 VILLAGE POND ROAD GUILFORD CT 06437
Business Address
Nandabalan Krishnan (Reporting) CIK: 0001733387 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38410 | Film No.: 21641094